Recombinant Klebsiella pneumoniae ATP synthase subunit a (atpB) represents a laboratory-produced version of the naturally occurring atpB protein found in K. pneumoniae bacteria. This protein is typically expressed in Escherichia coli expression systems to facilitate large-scale production and purification for research applications . The recombinant form often includes modifications such as histidine tags to enhance purification efficiency while maintaining the structural and functional properties of the native protein.
ATP synthase is a multi-subunit enzyme complex that plays a fundamental role in energy production in bacteria. It functions as a molecular machine that synthesizes adenosine triphosphate (ATP), the primary energy currency of cells, through the process of oxidative phosphorylation. The subunit a (atpB) is part of the F0 sector of ATP synthase, which is embedded in the bacterial membrane and forms the proton channel necessary for ATP synthesis.
Klebsiella pneumoniae has gained significant attention as a globally disseminated opportunistic pathogen capable of causing life-threatening infections. It has been identified as the causative agent in numerous hospital outbreaks, particularly affecting vulnerable populations such as newborns and adults in intensive care units . With the increasing prevalence of multidrug-resistant strains producing extended-spectrum β-lactamases, understanding the basic biology of this organism, including its energy metabolism machinery, has become critically important for developing new therapeutic strategies.
The atpB gene in K. pneumoniae encodes the ATP synthase subunit a. In genomic databases and scientific literature, it is also known by several synonyms:
This gene is part of the ATP synthase operon, which contains genes encoding various subunits of the ATP synthase complex. The coordinated expression of these genes ensures the proper assembly and function of the complete ATP synthase enzyme, which is essential for bacterial energy metabolism and survival.
The production of recombinant K. pneumoniae atpB typically employs bacterial expression systems, with E. coli being the most commonly used host organism. This expression system offers several advantages for recombinant protein production, including rapid growth, well-established genetic tools, and high protein yields .
For membrane proteins like atpB, expression can be challenging due to their hydrophobic nature and the potential for toxicity to the host cell. Specialized E. coli strains and expression vectors have been developed to overcome these challenges, often incorporating features such as tightly controlled promoters and fusion tags to enhance solubility and facilitate purification.
The purification of recombinant K. pneumoniae atpB typically involves a multi-step process designed to isolate the protein with high purity while maintaining its structural integrity. The general purification workflow includes:
Cell lysis to release the expressed protein
Membrane extraction using appropriate detergents
Affinity chromatography, leveraging the His-tag for selective binding
Optional additional purification steps (e.g., ion exchange or size exclusion chromatography)
Quality control assessment, typically by SDS-PAGE analysis
The purified protein is often lyophilized (freeze-dried) for long-term storage and stability . This process removes water while preserving the protein structure, resulting in a powder form that can be reconstituted when needed for experimental use.
The quality of purified recombinant atpB is typically assessed using several complementary methods:
SDS-PAGE to evaluate protein purity and molecular weight
Western blotting for identity confirmation
Mass spectrometry for detailed compositional analysis
Functional assays to verify biological activity
Commercial preparations of recombinant K. pneumoniae atpB typically achieve purity levels greater than 90%, as determined by SDS-PAGE analysis . This high level of purity is essential for ensuring reliable and reproducible results in downstream applications.
ATP synthase plays a central role in bacterial energy metabolism, serving as the final step in oxidative phosphorylation. The enzyme utilizes the energy stored in a transmembrane proton gradient to catalyze the synthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate, providing the energy currency essential for cellular functions.
The ATP synthase complex consists of two main portions:
F1 sector: Contains the catalytic sites for ATP synthesis and is located on the cytoplasmic side of the membrane
F0 sector: Embedded in the membrane and forms the proton channel
Energy production through ATP synthase is fundamental to numerous bacterial processes, including those directly related to virulence and pathogenicity:
Cell division and growth
Nutrient transport
Motility
Virulence factor production
Stress response mechanisms
Antibiotic resistance mechanisms
In K. pneumoniae, energy metabolism is particularly important for survival in diverse host environments and the expression of virulence factors . As a globally disseminated opportunistic pathogen, K. pneumoniae requires efficient energy production to establish and maintain infections, particularly in healthcare settings where it poses significant clinical challenges.
Given its essential role in bacterial energy metabolism, ATP synthase has emerged as a potential target for antimicrobial development. Several factors make it an attractive target:
Essential function for bacterial survival
Structural differences between bacterial and human ATP synthases that could allow for selective targeting
Surface accessibility of certain portions of the complex
Precedent for targeting ATP synthase in other organisms
Recent research has highlighted ATP synthase components as potential targets for novel antimicrobials against K. pneumoniae and related bacterial pathogens, particularly in light of increasing antibiotic resistance . The global emergence and spread of resistant strains underline the need for novel antimicrobials against K. pneumoniae, and ATP synthase components represent promising candidates for such development.
Recombinant K. pneumoniae atpB protein serves as a valuable tool for various basic research applications that enhance our understanding of bacterial physiology:
Structural studies to elucidate the architecture of bacterial ATP synthases
Functional assays to investigate energy coupling mechanisms
Antibody production for detection and localization studies
Protein-protein interaction studies to map ATP synthase assembly
These fundamental investigations contribute to our understanding of bacterial bioenergetics and may reveal unique features of K. pneumoniae energy metabolism that could be exploited for therapeutic purposes.
ATP synthase subunits have shown potential as diagnostic markers and immunological targets in various bacterial species. Similar to the approach used with M. pneumoniae ATP synthase beta subunit (AtpD), which was identified by serologic proteome analysis as a promising diagnostic antigen , K. pneumoniae atpB might serve similar purposes.
Potential applications include:
Development of serological assays for detecting K. pneumoniae infections
Screening for anti-ATP synthase antibodies in patient samples
Evaluation of immune responses to K. pneumoniae
Structure-based drug design targeting ATP synthase
The ATP synthase components of bacteria often elicit strong immune responses during infection, making them potentially valuable targets for diagnostic and immunological applications .
K. pneumoniae strains that produce extended-spectrum β-lactamases have become increasingly prevalent, limiting treatment options for infections caused by this pathogen . Many strains exhibit multidrug resistance, necessitating the use of "last-resort" antibiotics such as polymyxins .
In this context, research into novel targets, including ATP synthase components like atpB, has gained importance. An integrative, multi-omics approach for prioritizing Klebsiella pneumoniae drug targets has highlighted proteins involved in essential metabolic processes as promising candidates for antimicrobial development . Understanding the structure and function of atpB may contribute to the development of new antimicrobial strategies that could potentially overcome existing resistance mechanisms.
For experimental use, lyophilized atpB requires reconstitution. A typical reconstitution procedure involves:
Centrifuging the vial briefly prior to opening to bring contents to the bottom
Reconstituting the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Adding glycerol (typically to a final concentration of 5-50%) for long-term storage
Aliquoting the reconstituted protein to minimize freeze-thaw cycles
Detailed reconstitution protocols are usually provided by manufacturers and may vary depending on the specific preparation and intended application . The addition of glycerol serves as a cryoprotectant for frozen storage, helping to maintain protein integrity.
Several factors can affect the stability of recombinant atpB:
Temperature fluctuations
Repeated freeze-thaw cycles
Exposure to proteases
pH changes
Oxidation
To maximize stability, the protein is typically stored in a buffer containing stabilizing agents such as trehalose (6%), which helps maintain protein structure during lyophilization and storage . Quality control measures, including SDS-PAGE analysis to confirm purity (>90%), are essential for ensuring the reliability of experimental results using this recombinant protein.
KEGG: kpe:KPK_5538
Subunit a (atpB) in K. pneumoniae ATP synthase plays a critical role in ion translocation across the membrane, forming part of the membrane-embedded F₀ sector. Unlike many other bacterial ATP synthases that use protons as coupling ions, evidence suggests that K. pneumoniae complex I utilizes sodium ions as the exclusive coupling ion . The atpB subunit contains the channel through which these ions flow, creating an electrochemical gradient that drives the rotary mechanism of ATP synthesis.
The protein functions within a larger complex that couples the electrochemical gradient to conformational changes in the F₁ catalytic sector, enabling the phosphorylation of ADP to ATP. In reconstituted systems, this sodium ion gradient established during NADH oxidation has been demonstrated to drive ATP synthesis from ADP and phosphate .
Isolation of functional atpB presents unique challenges compared to other ATP synthase subunits due to its hydrophobic nature and membrane integration. Successful isolation requires:
Selection of appropriate detergents that maintain protein stability without disrupting critical structural features
Careful consideration of lipid environments that support native protein conformation
Temperature control throughout purification to prevent aggregation
Unlike soluble components of the F₁ sector, atpB requires membrane mimetics during all purification steps. For functional studies, reconstitution into proteoliposomes has proven effective, as demonstrated in experiments where K. pneumoniae complex I was successfully coupled with ATP synthase from I. tartaricus in a reconstituted system . This approach allowed researchers to observe the establishment of sodium ion gradients during NADH oxidation.
The optimal expression system depends on research objectives:
| Expression System | Advantages | Limitations | Best Applications |
|---|---|---|---|
| E. coli | High yields, genetic similarity to K. pneumoniae, established protocols | Potential inclusion body formation | Structural studies, antibody production |
| Cell-free systems | Avoids toxicity issues, direct incorporation into liposomes | Lower yields, higher cost | Functional studies requiring direct membrane insertion |
| Homologous expression | Native post-translational modifications, proper folding | More challenging genetic manipulation | Studies of protein-protein interactions within the complex |
For functional studies, E. coli C41(DE3) or C43(DE3) strains engineered for membrane protein expression often provide the best balance between yield and proper folding. Codon optimization should account for the high GC content typical of Klebsiella genes. The addition of fusion partners like MBP or SUMO can improve solubility, though these must be removed for functional assays.
The ion specificity of K. pneumoniae ATP synthase represents a fascinating divergence from many other bacterial ATP synthases. Research indicates that K. pneumoniae complex I uses Na⁺ as its exclusive coupling ion, rather than the more common H⁺ . This characteristic has significant implications for energy conservation strategies in this pathogen.
In reconstituted proteoliposome systems containing K. pneumoniae complex I and I. tartaricus ATP synthase, researchers observed:
Establishment of an electrochemical sodium gradient during NADH oxidation
Utilization of this Na⁺ gradient to drive ATP synthesis
Absence of detectable NADH-driven proton transport into proteoliposomes
Capability for reverse electron transfer when a sufficient transmembrane voltage (>30 mV) was present
These findings contrast with most model bacterial systems like E. coli, where protons serve as the primary coupling ion. Further investigations into the amino acid residues within atpB that determine this ion specificity would provide valuable insights into the evolutionary adaptations of K. pneumoniae energy metabolism.
Distinguishing between Na⁺-coupled and H⁺-coupled ATP synthesis requires carefully designed experiments:
Ion gradient manipulation: Establishing defined Na⁺ or H⁺ gradients across membranes containing reconstituted ATP synthase can reveal which ion drives ATP synthesis. For example, acidified thylakoids transferred to media with lower proton concentration demonstrated ATP synthesis driven by proton movement in chemiosmotic experiments .
Specific inhibitors: Compounds like EIPA (5-(N-ethyl-N-isopropyl)amiloride) selectively inhibit Na⁺ transport without affecting H⁺ transport.
Isotope exchange studies: Using ²²Na⁺ or tritiated water to track ion movement during ATP synthesis.
Site-directed mutagenesis: Modifying conserved residues in atpB that coordinate ion binding can reveal which ions are essential for function.
Biophysical measurements: Direct measurement of ion fluxes using fluorescent probes (SBFI for Na⁺, BCECF for H⁺) can correlate ion movement with ATP synthesis activity.
In studies with K. pneumoniae complex I, the absence of NADH-driven proton transport into proteoliposomes, coupled with the observation of Na⁺-dependent ATP synthesis, provided compelling evidence for exclusive Na⁺ coupling .
Mutations in atpB can significantly alter the coupling efficiency between ion translocation and ATP synthesis. Key effects include:
Ion selectivity changes: Mutations in the ion channel region can alter the preference between Na⁺ and H⁺, affecting the coupling ion used.
Proton/sodium leak: Some mutations create uncoupled pathways, allowing ions to flow without driving ATP synthesis, reducing efficiency.
Altered c-ring interaction: Since atpB interfaces with the rotating c-ring, mutations can affect the mechanical coupling between ion movement and rotary motion.
Stator stability impacts: As part of the stator structure, mutations in atpB can destabilize the entire complex, as observed in studies of ATP synthase assembly where absence of stator components led to complex disassembly .
Experimental approaches to studying these effects include:
Reconstitution of mutant proteins in proteoliposomes for direct measurement of ATP synthesis rates
Membrane potential measurements to assess ion leakage
Structural studies to correlate mutations with conformational changes
Molecular dynamics simulations to predict effects of specific residue alterations
For optimal reconstitution of K. pneumoniae atpB into functional proteoliposomes, the following methodology has proven effective:
Lipid preparation:
Mix E. coli polar lipids with phosphatidylcholine (7:3 ratio)
Dissolve in chloroform, evaporate under nitrogen, and resuspend in buffer (10 mM HEPES-KOH pH 7.5, 2.5 mM MgCl₂)
Sonicate to form unilamellar vesicles
Protein incorporation:
Add purified atpB (or complete ATP synthase) at a protein:lipid ratio of 1:50-100 (w/w)
Destabilize preformed liposomes with detergent (Triton X-100 or C₁₂E₈) at just above critical micelle concentration
Incubate 30 minutes at room temperature with gentle agitation
Detergent removal:
Add Bio-Beads SM-2 in sequential steps (first addition: 30 mg/ml, incubate 1 hour; second addition: 60 mg/ml, incubate 2 hours; third addition: 60 mg/ml, overnight at 4°C)
Alternatively, use controlled dialysis against detergent-free buffer
Proteoliposome collection:
Centrifuge at 200,000 × g for 30 minutes
Resuspend pellet in assay buffer
This protocol has been successfully employed in experiments demonstrating sodium ion cycling between complex I from K. pneumoniae and ATP synthase in reconstituted systems . For functional validation, ATP synthesis assays can be performed by establishing a sodium ion gradient across the proteoliposome membrane.
Measuring Na⁺-dependent ATP synthesis requires careful experimental design to establish and monitor sodium gradients:
Gradient establishment:
Preincubate proteoliposomes in buffer containing 100-200 mM NaCl
Rapidly dilute into Na⁺-free buffer with equivalent osmolarity (using choline chloride or KCl)
Alternatively, use valinomycin/K⁺ to establish a membrane potential
ATP synthesis assay:
Add ADP (2 mM) and Pi (5 mM) to the external medium
Incubate at 30°C for defined time intervals (30 seconds to 5 minutes)
Stop reaction with trichloroacetic acid (5% final concentration)
ATP quantification:
Use luciferin/luciferase assay for high sensitivity
Alternatively, use coupled enzyme assays (hexokinase/glucose-6-phosphate dehydrogenase) with spectrophotometric detection
Controls to include:
Gramicidin to dissipate Na⁺ gradient (negative control)
Parallel experiments substituting K⁺ or H⁺ gradients to assess ion specificity
Proteoliposomes without reconstituted protein
In studies with K. pneumoniae complex I and I. tartaricus ATP synthase, this approach demonstrated that the Na⁺ gradient established during NADH oxidation could drive ATP synthesis from ADP and phosphate . Additionally, reverse electron transfer experiments showed that the electrochemical sodium gradient generated by ATP hydrolysis could drive NADH formation, but only when the transmembrane voltage exceeded 30 mV .
Several complementary techniques are particularly effective for investigating interactions between atpB and other ATP synthase subunits:
Crosslinking studies:
Chemical crosslinkers with varying spacer arm lengths can capture interactions
Photo-activatable crosslinkers allow more specific targeting
Zero-length crosslinkers (carbodiimides) identify direct contacts
Co-immunoprecipitation approaches:
Genetic approaches:
Suppressor mutation analysis can identify compensatory mutations in other subunits
Bacterial two-hybrid systems adapted for membrane proteins
Cysteine scanning mutagenesis coupled with disulfide crosslinking
Structural biology methods:
Cryo-EM of intact complexes provides visualization of subunit interfaces
Mass spectrometry of crosslinked complexes identifies specific contact points
Hydrogen-deuterium exchange mass spectrometry reveals protected interfaces
When studying K. pneumoniae atpB, special consideration should be given to its role in the stator structure and its interaction with the c-ring, as these elements are critical for energy coupling.
Protein aggregation is a common challenge when expressing hydrophobic membrane proteins like atpB. Effective strategies include:
Expression optimization:
Reduce induction temperature to 18-20°C
Use weaker promoters or lower inducer concentrations
Express in specialized strains like C41(DE3) designed for membrane proteins
Solubilization approaches:
Screen multiple detergents (DDM, LMNG, LDAO) at various concentrations
Add stabilizing agents like glycerol (10%) or specific lipids
Use native-source lipids during extraction
Fusion partner strategies:
N-terminal fusion with MBP or SUMO can improve solubility
C-terminal GFP fusion allows monitoring of proper folding
TEV or SUMO protease cleavage sites for tag removal
Co-expression options:
Co-express with natural partner subunits to promote complex assembly
Include molecular chaperones (GroEL/ES, DnaK/J) to assist folding
Co-express with specific lipid biosynthesis enzymes
When conventional approaches fail, cell-free expression systems offer an alternative that allows direct incorporation into nanodiscs or liposomes, bypassing the aggregation-prone solubilization step.
Discrepancies in ATP synthesis measurements can arise from multiple factors. Systematic troubleshooting approaches include:
Experimental standardization:
Precisely control temperature, as even small variations significantly affect enzyme kinetics
Standardize protein:lipid ratios in reconstitution
Carefully control ion gradients across membranes
Technical considerations:
Validate ATP detection methods with known standards
Account for background ATP contamination in reagents
Consider ATPase activity that may mask synthesis
Sample preparation factors:
Assess protein orientation in membranes (inside-out vs. right-side-out)
Quantify actual protein incorporation efficiency
Verify integrity of reconstituted proteoliposomes
Analysis approaches:
Use initial rate measurements to avoid gradient dissipation effects
Apply appropriate controls (uncouplers, specific inhibitors)
Consider statistical approaches for replicate analysis
In studies of K. pneumoniae complex I, researchers demonstrated conclusively that Na⁺ was used as the exclusive coupling ion . Contradictory results in similar systems might arise from subtle differences in experimental setup or from contaminating ion transport pathways.
Research on K. pneumoniae atpB has significant implications for developing targeted therapeutics:
Exploiting unique ion specificity:
Targeting unique structural features:
Detailed structural characterization of atpB could reveal bacterial-specific regions
Regions involved in stator assembly represent potential targets, as demonstrated by the essentiality of stator components in apicomplexan parasites
Small molecules disrupting crucial subunit interactions could destabilize the complex
Metabolic considerations:
K. pneumoniae shows distinctive metabolic adaptations linked to energy production
Understanding connections between ATP synthase function and metabolic flexibility, as observed with the citrate synthase gene (gltA) , could reveal synergistic targets
Combined targeting of ATP synthesis and specific metabolic pathways may overcome compensatory mechanisms
Resistance mechanisms:
Studies of natural variations in atpB sequence across clinical isolates may reveal adaptations affecting drug binding
Understanding such mechanisms proactively can inform inhibitor design strategies
The demonstrated importance of ATP synthase function for pathogen viability, as shown in studies where disruption of stator components led to parasite death , underscores the potential of this complex as a therapeutic target.
Several fascinating evolutionary questions remain regarding Na⁺-coupled ATP synthesis in K. pneumoniae:
Addressing these questions will require comparative genomic approaches, biochemical characterization across species, and ecological studies examining K. pneumoniae in its natural environments and host associations.